Malnutrition

• FDA approval · 2023-05-17
  FDA Approved: KABIVEN — Supplemental Application (Fresenius Kabi USA, LLC)

  FDA approved a supplemental application for KABIVEN, a complete parenteral nutrition product, confirming its labeling and continued use for …

• FDA approval · 2020-07-02
  FDA Approved: TRALEMENT — Original Application (American Regent, Inc.)

  The FDA approved TRALEMENT (trace elements injection 4) from American Regent, Inc. under an Original Application to prevent trace element de…

• FDA approval · 2020-05-08
  FDA Approved: SMOFLIPID — Supplemental Application (Fresenius Kabi USA, LLC)

  The FDA approved a supplemental application for SMOFLIPID submitted by Fresenius Kabi USA, LLC.

• FDA approval · 2016-06-09
  FDA Approved: KABIVEN — Supplemental Application (Fresenius Kabi USA, LLC)

  FDA approved a supplemental application for Kabiven, a parenteral nutrition product from Fresenius Kabi USA, LLC.

• FDA approval · 2016-04-11
  FDA Approved: KABIVEN — Supplemental Application (Fresenius Kabi USA, LLC)

  FDA approved a supplemental NDA for Kabiven, a parenteral nutrition emulsion (dextrose, lipids, amino acids and electrolytes). The approval …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2014-09-15
  FDA Approved: CLINIMIX E — Supplemental Application (Baxter Healthcare Company)

  FDA approved a supplemental application for Clinimix E, Baxter's intravenous parenteral nutrition product, approving its updated formulation…